Insider trades
M33 Growth I, Director of Starling Oncology STLN, has filed 0 purchases and 6 sales on the open market. The latest trade was on 25/11/18.
M33 Growth I
Director
- Company
- Starling Oncology STLN
- First filing
- 25/03/28
- Trades
- 11 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- No record
- Last trade
- 25/11/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
STLN | Open-market sale | 25/09/04 | 25/09/05 | 6,700,000 sh2 trades | $3.09avg. | $20,703,000 | No record |
STLN | Open-market sale | 25/06/05 | 25/06/09 | 750,000 sh2 trades | $3.05avg. | $2,287,500 | No record |
STLN | Open-market sale | 25/05/20 | 25/05/22 | 2,000,000 sh2 trades | $2.71avg. | $5,420,000 | No record |